Free Trial
NASDAQ:VXRT

Vaxart (VXRT) Stock Price, News & Analysis

Vaxart logo
$0.45 +0.10 (+29.05%)
As of 07/11/2025 03:59 PM Eastern

About Vaxart Stock (NASDAQ:VXRT)

Key Stats

Today's Range
$0.33
$0.47
50-Day Range
$0.30
$0.70
52-Week Range
$0.26
$1.07
Volume
4.67 million shs
Average Volume
2.66 million shs
Market Capitalization
$102.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Buy

Company Overview

Vaxart Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

VXRT MarketRank™: 

Vaxart scored higher than 68% of companies evaluated by MarketBeat, and ranked 270th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vaxart has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vaxart has received no research coverage in the past 90 days.

  • Read more about Vaxart's stock forecast and price target.
  • Earnings Growth

    Earnings for Vaxart are expected to grow in the coming year, from ($0.39) to ($0.38) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaxart is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaxart is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vaxart has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Vaxart's valuation and earnings.
  • Percentage of Shares Shorted

    0.37% of the float of Vaxart has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaxart has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaxart has recently decreased by 96.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vaxart does not currently pay a dividend.

  • Dividend Growth

    Vaxart does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.37% of the float of Vaxart has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaxart has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaxart has recently decreased by 96.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Vaxart has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Vaxart this week, compared to 2 articles on an average week.
  • Search Interest

    8 people have searched for VXRT on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Vaxart to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaxart insiders have bought more of their company's stock than they have sold. Specifically, they have bought $49,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.90% of the stock of Vaxart is held by insiders.

  • Percentage Held by Institutions

    Only 18.05% of the stock of Vaxart is held by institutions.

  • Read more about Vaxart's insider trading history.
Receive VXRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter.

VXRT Stock News Headlines

OTC Markets Group Welcomes Vaxart, Inc. to OTCQX
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
See More Headlines

VXRT Stock Analysis - Frequently Asked Questions

Vaxart's stock was trading at $0.6621 at the beginning of the year. Since then, VXRT shares have decreased by 32.4% and is now trading at $0.4478.

Vaxart, Inc. (NASDAQ:VXRT) announced its earnings results on Tuesday, May, 13th. The biotechnology company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). The biotechnology company earned $20.88 million during the quarter, compared to analyst estimates of $2.85 million. Vaxart had a negative net margin of 122.63% and a negative trailing twelve-month return on equity of 91.89%.
Read the conference call transcript
.

Vaxart's stock reverse split on the morning of Wednesday, February 14th 2018.The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Shares of VXRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaxart investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Fortress Biotech (FBIO), Assertio (ASRT), Ovid Therapeutics (OVID) and KALA BIO (KALA).

Company Calendar

Last Earnings
5/13/2025
Today
7/12/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VXRT
Previous Symbol
NASDAQ:NABI
CIK
72444
Employees
120
Year Founded
2004

Price Target and Rating

High Price Target
$4.00
Low Price Target
$2.00
Potential Upside/Downside
+569.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$66.95 million
Net Margins
-122.63%
Pretax Margin
-121.98%
Return on Equity
-91.89%
Return on Assets
-38.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.64
Quick Ratio
0.64

Sales & Book Value

Annual Sales
$47.40 million
Price / Sales
2.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.26 per share
Price / Book
1.72

Miscellaneous

Outstanding Shares
228,310,000
Free Float
222,374,000
Market Cap
$102.24 million
Optionable
Optionable
Beta
1.14

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:VXRT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners